Short answer
SBC Medical Group Holdings Inc (SBC) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Press release announces SBC Medical Group Holdings’ quarterly results for the period ended September 30, 2026.
SBC Medical Group Holdings Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release announces SBC Medical Group Holdings’ quarterly results for the period ended September 30, 2026
- Exhibit 99.1 contains the financial results and management commentary investors need for performance assessment
Item 7.01 · Regulation FD Disclosure
- Investor presentation covers 3Q 2026 results for quarter ended September 30, 2026
- Presentation posted November 13, 2026 at SBC Medical Group’s investor-relations website
- Quarterly business and financial details require review of the linked presentation
Item EX-99.1 · Exhibit EX-99.1
- 3Q26 revenue $59 million, up 35%, driven by higher management fees, service-fee revisions and Waqoo consolidation
- Operating income $26 million, up 66%, with 45% margin, indicating substantial operating leverage
- Net income attributable to SBC Medical $16 million, up 22%, while margin declined 3 points to 27%
- Adjusted EBITDA $28 million, up 66%, with margin expanding 9 points to 47%
- Clinic network reached 293 locations, up 36 year-over-year, with $154 million net cash supporting growth investment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SBC Medical Group Holdings Inc 8-K filings
Get the next SBC 8-K as it lands
Follow SBC for push alerts, or ask the research agent what this filing means.